Ajax-Loading

Company Selected - Sino Biopharmaceutical Ltd - Income Statement















Ajax-Loading
Fiscal Year is From January To December - All Figures are in HKD, Thousands, Except for the Diluted EPS Figure06/30/202503/31/202512/31/202409/30/2024View Chart

Total Revenue

30,178,10128,779,65427,929,46631,497,256

[-] Cost of Goods Sold (COGS) incl. D&A

5,498,0325,281,6295,163,4775,527,700

Hid COGS excluding D&A

5,498,0325,281,6295,163,4775,527,700

Hid Depreciation & Amortization Expense

0.00.00.00.0

Gross Profit

24,680,06923,498,02522,765,98925,969,556

[-] Operating Expenses

18,602,19517,624,28316,971,93018,920,657

Hid Selling General Administrative (SG&A)

12,696,16112,111,90611,764,16013,361,690

Hid Research & Development

5,623,3485,229,6914,925,0833,744,723

Hid Other Operating Expenses

282,686282,687282,6881,814,243

Operating Income

6,077,8745,873,7415,794,0597,048,899

[-] Net Interest Income

- - - -

Hid Interest Expense

562,653615,337561,826694,877

Hid Interest Income

313,034.04542,781.75542,782670,328.82

Hid Total Other Finance Cost

-249,619-72,555-19,044-24,548

Total Other Income Expense Net

1,502,808405,647-691,144-351,227

Income Before Tax

7,580,6816,279,3895,102,9156,257,091

Tax Provision

685,632766,645583,030938,365

[-] Net Income Applicable To Common Shares

4,083,7385,198,1945,012,4795,509,290

Hid [-] Net Income

3,856,8333,566,9133,381,1984,104,913

HidHid [-] Net Income Including Non-Controlling Interests

6,895,0495,512,7444,519,8855,318,725

HidHidHid Net Income From Continuing Ops

- - - -

HidHidHid Discontinued Operations

- - - -

HidHid Minority Interest Expense

3,038,2161,945,8311,138,6871,213,812

Hid Preferred Stock And Other Adjustments

-226,905-1,631,281-1,631,281-1,404,376

Diluted EPS

0.230.30.290.31

Diluted Average Shares

18,025,87518,025,87517,093,15618,180,281

EBITDA

6,048,1475,917,9775,924,2624,904,622

EBIT

5,056,7384,967,5384,998,1744,199,447